How Early Formulation Development Ensures Clinical Success | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

How Early Formulation Development Ensures Clinical Success

Myke Scoggins, Ph.D. (Director, Product Development, Recro Gainesville)

Location: Exhibitor Showcase Theater

Date: Tuesday, April 30

Time: 3:30pm - 3:55pm

Track: Exhibitor Showcase

Vault Recording: TBD

Early formulation work can be one of the keys to success for clinical trials. Through simple formulations or full-blown design of experiments, careful planning of early-phase strategies are critical for downstream success. We will discuss how this can be done efficiently and effectively to help ensure success when clinical trials commence.